CB
Bourquin, Carole
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Role of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive Review | Non-coding RNA |  | 2024 | 171 | 71 | ||
| GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model | Frontiers in immunology | | 2024 | 192 | 69 | ||
| Dual targeting of H2S synthesizing enzymes; cystathionine β-synthase and cystathionine γ-lyase by miR-939-5p effectively curbs triple negative breast cancer | Heliyon | | 2023 | 192 | 63 | ||
| Role of Cystathionine β-Synthase and 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation, Migration, and Bioenergetics of Murine Breast Cancer Cells | Antioxidants | | 2023 | 315 | 121 | ||
| Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer | Oncoimmunology | | 2023 | 242 | 104 | ||
| PEGylated Gold Nanoparticles Target Age-Associated B Cells In Vivo | ACS nano | | 2022 | 363 | 60 | ||
| Inhibition of IL-1β release from macrophages targeted with necrosulfonamide-loaded porous nanoparticles | Journal of controlled release | | 2022 | 392 | 387 | ||
| HMGB1 promotes CXCL12‐dependent egress of murine B cells from Peyer's patches in homeostasis | European Journal of Immunology | | 2021 | 257 | 172 | ||
| The interleukin-1 cytokine family members: role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy | Cytokine & growth factor reviews | | 2021 | 271 | 177 | ||
| Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice | ACS Nano | | 2021 | 397 | 535 | ||
| Silver-Containing Titanium Dioxide Nanocapsules for Combating Multidrug-Resistant Bacteria | International Journal of Nanomedicine | | 2020 | 484 | 178 | ||
| Médiateurs de l'aspirine dans l'arsenal anticancéreux ? | Revue médicale suisse | | 2020 | 321 | 430 | ||
| Polymer-coated gold nanospheres do not impair the innate immune function of human B lymphocytes in vitro | ACS Nano | | 2019 | 451 | 540 | ||
| Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study | European Journal of Pharmaceutics and Biopharmaceutics | | 2019 | 587 | 701 | ||
| Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation | Biomaterials | | 2019 | 539 | 663 | ||
| CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes | Journal of Experimental Medicine | | 2019 | 491 | 364 | ||
| Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists | Pharmacological Research | | 2019 | 549 | 1,114 | ||
| Bionanomaterials for the Delivery of Cancer Immunotherapy | Chimia | | 2019 | 431 | 299 | ||
| Hook length of the bacterial flagellum is optimized for maximal stability of the flagellar bundle | PLOS Biology | | 2018 | 484 | 346 | ||
| Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation | International Journal of Pharmaceutics | | 2018 | 644 | 853 | ||
| Engineered hybrid spider silk particles as delivery system for peptide vaccines | Biomaterials | | 2018 | 574 | 454 | ||
| Antimicrobial silver-filled silica nanorattles with low immunotoxicity in dendritic cells | Nanomedicine | | 2017 | 547 | 550 | ||
| Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade | Oncoimmunology | | 2017 | 248 | 208 | ||
| NAB2 is a novel immune stimulator of MDA-5 that promotes a strong type I interferon response | Oncotarget | | 2017 | 515 | 229 | ||
| A rapid screening method to evaluate the impact of nanoparticles on macrophages | Nanoscale | | 2017 | 506 | 395 | ||
| Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses | Oncoimmunology | | 2016 | 245 | 157 | ||
| TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function | Oncoimmunology | | 2016 | 236 | 188 | ||
| P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model | Journal for immunotherapy of cancer | | 2014 | 27 | 39 | ||
| Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells | Retrovirology | | 2012 | 31 | 40 |
